Sangamo Therapeutics (SGMOQ) Other Operating Expenses (2012 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly Other Operating Expenses of $13.2 million for Q4 2025, up 1029.27% quarter-over-quarter from $1.2 million in Q2 2024.
Sangamo Therapeutics (SGMOQ) Other Operating Expenses (2012 - 2025) Analysis & Trends
Sangamo Therapeutics' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $13.2 million for Q4 2025.
- In Q4 2025, Other Operating Expenses changed N/A year-over-year to $13.2 million; the TTM figure through Dec 2025 stood at $13.2 million (up 139.72% YoY), while the FY2025 annual figure was $13.2 million, up 139.72% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $13.2 million, up from $1.2 million in the prior quarter.
- The five-year high for Other Operating Expenses was $58.6 million in Q1 2023, with the low at $296000.0 in Q4 2023.
- The 3-year median for Other Operating Expenses is $13.2 million (2025), against an average of $24.8 million.
- Peak annual rise in Other Operating Expenses reached 92.57% in 2024, while the deepest fall reached 97.72% in 2024.
- Sangamo Therapeutics' Other Operating Expenses stood at $296000.0 in 2023, then surged by 295.95% to $1.2 million in 2024, then surged by 1029.27% to $13.2 million in 2025.
- Business Quant data shows SGMOQ's Other Operating Expenses at $13.2 million in Q4 2025, $1.2 million in Q2 2024, and $4.3 million in Q1 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.24 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 4.35 Mn |
| Dec 31, 2023 | 296,000.00 |
| Sep 30, 2023 | 44.80 Mn |
| Jun 30, 2023 | 51.35 Mn |
| Mar 31, 2023 | 58.57 Mn |
| Dec 31, 2019 | 53.38 Mn |
| Dec 31, 2012 | -1,000.00 |
| Mar 31, 2012 | 1,000.00 |